🇨🇦 DelNS1-2019-nCoV-RBD-OPT1 in Canada

DelNS1-2019-nCoV-RBD-OPT1 (DelNS1-2019-nCoV-RBD-OPT1) regulatory status in Canada.

Marketing authorisation

DelNS1-2019-nCoV-RBD-OPT1 in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is DelNS1-2019-nCoV-RBD-OPT1 approved in Canada?

Yes. Health Canada has authorised it.

Who is the marketing authorisation holder for DelNS1-2019-nCoV-RBD-OPT1 in Canada?

The University of Hong Kong is the originator. The local marketing authorisation holder may differ — check the official source linked above.